Reich & Binstock
Free Initial Consultation
Toll Free: 877-643-3099
Local: 713-352-7883
877-643-3099 713-352-7883

January 2014 Archives

A 'gliptin' drug singled out for FDA scrutiny

Since February, the U.S Food and Drug Administration has been investigating a potential link between the use of the diabetes drug saxagliptin and heart failure. AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company have marketed saxagliptin as the brand-name drugs Onglyza and Kombiglyze XR.

A 'gliptin' drug singled out for FDA scrutiny

Since February, the U.S Food and Drug Administration has been investigating a potential link between the use of the diabetes drug saxagliptin and heart failure. AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company have marketed saxagliptin as the brand-name drugs Onglyza and Kombiglyze XR.

Contact Us

Contact Us For Legal Advice

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Map & Directions